Calcification leads to 75%-85% of blockage in the arteries.However, the researchers in National Aeronautics and Space Administration (NASA) and in Finland, aided by Mayo Clinic and Washington Hospital Center have found a new approach to reduce calcium deposits in the arteries, along with reducing cholestrol levels and chest pains. This is not the painful intravenous chelation, it’s a nanobacteria cocktail of tetracycline, EDTA and nutraceuticals. This regimen was tested on heart patients with a irrecoverable condition and the Cleveland Clinic in Florida used the EDTA-tetracycline long-term chemotherapy for patients suffering from prostate diseases.
The only flaw with this approach is its application. The new approach is already available in the USA and thousands of patients are resorting to this approach. But doctors need to make this approach accessible to more number of patients who are in dire need of a convenient reversal of heart diseases.